Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer

Gynecologic Oncology - Tập 105 - Trang 414-417 - 2007
Shannon N. Westin1, Elizabeth N. Skinner1, Michele Jonsson Funk2, Paola M. Gehrig1, Linda Van Le1
1Department of Gynecologic Oncology and Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, 4013 Old Clinic, CB 7570, Chapel Hill, NC 27599, USA
2Department of Epidemiology and Center for Women's Health Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

Tài liệu tham khảo

Groopman, 1999, Chemotherapy-induced anemia in adults: incidence and treatment, J. Natl. Cancer Inst., 91, 1616, 10.1093/jnci/91.19.1616 Abels, 1993, Erythropoeitin for anaemia in cancer patients, Eur. J. Cancer, 29A, S2, 10.1016/S0959-8049(05)80281-3 Vansteenkiste, 2002, Double blind, placebo-controlled, randomized phase 3 trial of darbepoetin alfa in lung cancer patients receiving chemotherapy, J. Natl. Cancer Inst., 94, 1211, 10.1093/jnci/94.16.1211 Kurz, 1997, Erythropoeitin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double blind placebo-controlled multicenter study, Gynecol. Oncol., 65, 461, 10.1006/gyno.1997.4675 Jilani, 1998, Impact of epoetin alfa in chemotherapy-associated anemia, Semin. Hematol., 25, 571 Glaspy, 1997, The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem, Semin. Oncol., 34, 20 Ferrario, 2004, Treatment of cancer-related anemia with epoetin alfa: a review, Cancer Treat. Rev., 30, 563, 10.1016/j.ctrv.2004.04.005 Rosenzweig, 2004, The decision to prematurely terminate a trial of r-HuEPO due to thrombotic events, J. Pain Symptom Manage., 27, 185, 10.1016/j.jpainsymman.2003.06.010 Wun, 2003, Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin, Cancer, 98, 1514, 10.1002/cncr.11700 Procrit® (epoetin alfa) prescribing information. 2004. Available at http://www.orthobiotech.com/common/prescribing_information/PROCRIT/PDF/ProcritBooklet.pdf. Accessed 5 June 2006. Aranesp® (darbepoetin alfa) prescribing information. 2004. Available at http://www.aranesp.com/pdf/aranesp_PI.pdf. Accessed 5 June 2006. Besarab, 1998, The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin, N. Engl. J. Med., 339, 584, 10.1056/NEJM199808273390903